medigraphic.com
ISSN 2007-087X (Print)
Órgano Oficial de la Sociedad Mexicana de Ortopedia Pediátrica

2013, Number 2

<< Back Next >>

Rev Mex Ortop Ped 2013; 15 (2)

The use of coralline, autologous bone graft and application of stem cells in various bone diseases in children

Olalde HM, Silva PSR, Ayala CJL

Language: Spanish
References: 18
Page: 85-90
PDF size: 256.86 Kb.


ABSTRACT

Background: The hydroxyapatite implants and transplant of stem cells, is an alternative of treatment of new generation which has been showed goods results in the treatment of along kind of pathologies.1 In the last years this kind of treatment has been a development and useful, multicenter studies has been made around the world showed that the use of stem cell transplants and hydroxyapatite inserts has good resume for the treatment of many kinds of traumatic injuries. Analyzing the kind of lesion and use of therapies patients could show a big destruction of the bone tissues and few options let for treatment. Before the analysis of world literature, we have coming to conclusion that some of this news techniques use in treatment of many kinds of pathologies in the skeletal system could have a better on going in treatment use these alternatives. Materials and methods: Was study 10 patients were treated with autologous bone graft, hidroxiapatite and stem cells, with a following for demonstrate a clinical improvement. Results: 90% of patients had a clinical improvement without complications and only 10% (1 patient) had an unfavorable evolution. Conclusions: Treatment with hydroxyapatite grafts and bone grafts showed be a good alternative in the treatment of various conditions of bone system in the patients so require.


REFERENCES

  1. Usas A, Mačiulaitis J, Mačiulaitis R, Jakuboniene N, Milašius A, Huard J. Skeletal muscle-derived stem cells: implications for cell-mediated therapies. Medicina (Kaunas). 2011; 47(9): 469-479.

  2. Khosla S, Westendorf JJ, Mödder UI. Concise Review: insights from normal bone remodeling and stem cell-based therapies for bone repair. Stem Cells. 2010; 28(12): 2124-2128. doi:10.1002/stem.546.

  3. Gurudutta GU, Satija NK, Singh VK, Verma YK, Gupta P, Tripathi RP. Stem cell therapy: a novel & futuristic treatment modality for disaster injuries. Indian J Med Res. 2012; 135: 15-25.

  4. Clines GA. Prospects for osteoprogenitor stem cells in fracture repair and osteoporosis. Curr Opin Organ Transplant. 2010; 15(1): 73-78. doi:10.1097/MOT.0b013e328333d52c.

  5. Dupont KM, Sharma K, Stevens HY, Boerckel JD, García AJ, Guldberga RE. Human stem cell delivery for treatment of large segmental bone defects. Proc Natl Acad Sci. 2010; 107(8): 3305-3310.

  6. Fong EL, Chan CK, Goodman SB. Stem cell homing in musculoskeletal injury. Biomaterials. 2011; 32(2): 395-409. doi: 10.1016/j.biomaterials.2010.08.101.

  7. Ferrer LY, Vergara PJJ, Oquendo VP. Hidroxiapatita como sustituto del tejido óseo.

  8. Rienzo AD, Iacoangeli M, Somma LG, Alvaro L, Nocchi N, Scerrati M. Shape modifications of porous hydroxyapatite prostheses to improve rigid implant fixation: experience in 12 cases. Surg Neurol Int. 2012; 3: 161.

  9. Nishioka K, Imae S, Kitayama M, Miki J, Okawa T, Itakura T. Percutaneus vertebroplasty using hidroxyapatite blocks for the treatment of vertebral body fracture. Neurol Med Chir (Tokyo). 2009; 49: 501-506.

  10. Matsumine A, Myoui A, Kusuzaki K, Araki N, Seto M, Yoshikawa H et al. Calcium hydroxyapatite ceramic implants in bone tumour surgery. J Bone Joint Surg Br. 2004; 86: 719-725.

  11. Radl R, Aigner C, Hungerford M, Pascher A, Windhager R. Proximal femoral bone loss and increased rate of fracture with a proximally hydroxyapatite-coated femoral component. J Bone Joint Surg Br. 2000; 82B: 1151-1155.

  12. Schewelov Tv, Ahlborg H, Sanzén L, Besjakov J, Carlsson A. Fixation of the fully hydroxyapatite-coated Corail stem implanted due to femoral neck fracture 38 patients followed for 2 years with RSA and DEXA. Acta Orthopaedica. 2012; 83(2): 153-158.

  13. López-AC, Cebrián Carretero JL, González MJ, Burgueńo M. Aneurysmal bone cyst of the mandible: case presentation and review of the literature. Med Oral Patol Oral Cir Bucal. 2007; 12: E401-3.

  14. van der Wal BC, Vischjager M, Grimm B, Heyligers IC, Tonino AJ. Periprosthetic fractures around cementless hydroxyapatite-coated femoral stems. Int Orthop. 2005; 29: 235-240.

  15. Kalra GD, Agarwal A. Experience with free fibula transfer with screw fixation as a primary modality of treatment for congenital pseudarthosis of tibia in children-series of 26 cases. Indian J Plast Surg. 2012; 45(3): 468-477.

  16. Voigt JD, Mosier M. Hydroxyapatite (HA) coating appears to be of benefit for implant durability of tibial components in primary total knee arthroplasty. A systematic review of the literature and meta-analysis of 14 trials and 926 evaluable total knee arthroplasties. Acta Orthop.2011; 82(4): 448-459.

  17. Tauchmanova L, Colao A, Lombardi G, Rotoli B, Selleri C. Bone loss and its management in long-term survivors from allogeneic stem cell transplantation. J Clin Endocrinol Metab. 2007; 92: 4536-4545.

  18. Seo S, Na K. Mesenchymal stem cell-based tissue engineering for chondrogenesis. J Biomed Biotechnol. 2011; ID 806891.




2020     |     www.medigraphic.com